etoposide has been researched along with Agranulocytosis in 34 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (23.53) | 18.7374 |
1990's | 21 (61.76) | 18.2507 |
2000's | 5 (14.71) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Xie, Y; Zheng, W; Zhu, J | 1 |
Avilés, A; Calva, A; Fernández, R; Huerta-Guzmán, J; Nambo, MJ; Neri, N | 1 |
Allen, PK; Blumenschein, GR; Cox, JD; Fossella, FV; Garza, VP; Glisson, BS; Herbst, RS; Kaplan, B; Kies, MS; Komaki, R; Kurie, J; Lee, HK; Lee, JS; Liao, Z; Lu, C; Milas, L; Mooring, D; Papadimitrakopoulou, VA; Pisters, KM; Stevens, CW; Tucker, SL; Zinner, RG | 1 |
Goulet, K; Grignon, S | 1 |
Aisner, J; Wiernik, PH | 1 |
Klastersky, J; Longeval, E; Nicaise, C; Stryckmans, P | 1 |
Aisner, J; de Jongh, CA; Finley, RS; Joshi, JH; Schimpff, SC; Wade, JC; Wiernik, PH | 1 |
Fehr, J; Frick, P; Gmuer, J; Honegger, H; Martz, G; Sauter, C | 1 |
Cabanillas, F; Hagemeister, FB; Lee, MS; McLaughlin, P; Pate, O; Rodriguez, MA; Romaguera, J; Sarris, A; Swan, F; Younes, A | 1 |
Fujihara, M; Kyo, T; Myoken, Y; Sugata, T | 1 |
Arioka, H; Eguchi, K; Karato, A; Kunikane, H; Nishio, M; Ohe, Y; Oshita, F; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
Abate, G; Aglietta, M; Andorno, S; Colombi, S; D'Andrea, P; Marcolin, P; Monteverde, A; Silvestri, I; Tafuto, S; Volta, C | 1 |
Ansari, R; Einhorn, LH; Faylona, EA; Gonin, R; Loehrer, PJ; Sandler, AB | 1 |
Dahrouge, S; Evans, WK; Goss, G; Latreille, J; Logan, D; Maroun, JA; Shepherd, FA; Stewart, DJ; Warner, E; Wierzbicki, R | 1 |
Beaujean, F; Bourhis, JH; Chazard, M; Hayat, M; Ibrahim, A; Lhomme, C; Maraninchi, D; Ostronoff, M; Viens, P; Zambon, E | 1 |
Christiansen, NP; Davis, MP; Fay, JW; Herzig, GP; Herzig, RH; Lynch, J | 1 |
Bosnjak, SM; Mitrović, LB; Nesković-Konstantinović, ZB; Radulović, SS | 1 |
Fossella, FV; Glisson, BS; Hong, WK; Lee, JS; Murphy, WK; Perez-Soler, R; Shin, DM | 1 |
Abe, N; Adachi, Y; Fujieda, J; Gotoh, T; Kosugi, M; Koyanagi, T; Maru, A; Nagamori, S; Nonomura, K; Ohashi, N; Sakakibara, N; Sakashita, S; Seki, T; Shinno, Y; Shinohara, N; Togashi, M; Toyota, K | 1 |
Ben-Shahar, M; Epelbaum, R; Faraggi, D; Haim, N; Leviov, M; Tsuri-Etzioni, A | 1 |
Huhn, D; Kingreen, D; Kirsch, A; Kleiner, S; Schwaner, I; Schwella, N; Siegert, W | 1 |
Apel, D; Maj, S; Mariańska, B; Seferyńska, I | 1 |
Anton, A; Barneto, I; Font, A; Garcia-Giron, C; Moyano, AJ; Puerto, JM; Rosell, R; Salvador, A; Sanchez, JJ; Tres, A | 1 |
Barbarano, L; Bernuzzi, P; Gargantini, L; Morra, E; Nosari, A; Pungolino, E; Santoleri, L | 1 |
Dommann-Scherrer, C; Hassam, S; Maurer, R; Odermatt, BF; Risti, B; Zimmermann, D | 1 |
Dhingra, HH; Greenberg, J; Hong, WK; Lee, JS; Shirinian, M | 1 |
Evans, WK; Goss, PE; Latreille, J; Logan, D; Maroun, J; Paul, K; Shepherd, FA; Stewart, D; Warner, E | 1 |
Becton, DL; Berry, DH; Kletzel, M | 1 |
Deisseroth, A; Dicke, K; Dunphy, F; Fogel, B; Huan, S; Jagannath, S; Souza, L; Spitzer, G; Taylor, K; Ventura, G | 1 |
Anderson, T; Kohler, W; Mangalik, A; Neidhart, JA; Plauche, A; Quenzer, RW; Rinehart, JJ; Stidley, C | 1 |
James, KW; Mort, D; Webster, DJ; Wilkins, M; Williams, MV | 1 |
Devereaux, S; Goldstone, AH; Gribben, JG; Linch, DC; McMillan, A; Patterson, K | 1 |
Calame, W; Mattie, H | 1 |
Bosl, GJ; Golbey, RB; Herr, H; MacDonald, G; Morse, M; Sogani, P; Vogelzang, N; Whitmore, W; Yagoda, A | 1 |
13 trial(s) available for etoposide and Agranulocytosis
Article | Year |
---|---|
Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Killer Cells, Natural; Leucovorin; Lung Neoplasms; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Radiotherapy, Adjuvant; Remission Induction; Skin Neoplasms; Treatment Outcome | 2003 |
Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Confidence Intervals; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Radiation Pneumonitis; Radiation-Protective Agents; Radiotherapy Dosage; Survival Analysis; Treatment Outcome | 2004 |
Trimethoprim/sulfamethoxazole versus placebo: a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Double-Blind Method; Doxorubicin; Etoposide; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Random Allocation; Sulfamethoxazole; Trimethoprim | 1983 |
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Life Tables; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Neoplasm Staging; Oncogenes; Polymerase Chain Reaction; Prednisone; Procarbazine; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Remission Induction; Treatment Outcome; Vincristine | 1994 |
Phase I study of CPT-11 and etoposide in patients with refractory solid tumors.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Irinotecan; Male; Middle Aged; Neoplasms; Treatment Outcome | 1993 |
Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial.
Topics: Administration, Oral; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Hematologic Diseases; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Analysis | 1995 |
Daily oral etoposide in metastatic breast cancer.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis | 1996 |
[Effective administration of recombinant granulocyte colony-stimulating factor to prevent granulocytopenia due to combination chemotherapy for testicular germ cell tumors].
Topics: Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Male; Recombinant Proteins; Testicular Neoplasms | 1996 |
Dexamethasone, etoposide, ifosfamide, and cisplatin as second-line therapy in patients with aggressive non-Hodgkin's lymphoma.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Salvage Therapy; Treatment Outcome | 1997 |
High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission Induction; Salvage Therapy; Transplantation, Autologous | 1997 |
[Preliminary treatment results of relapsed or refractory acute leukemia using two and three drug regimens].
Topics: Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Idarubicin; Male; Middle Aged; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction | 1998 |
Increasing dose intensity of cisplatin-etoposide in advanced nonsmall cell lung carcinoma: a phase III randomized trial of the Spanish Lung Cancer Group.
Topics: Adult; Aged; Agranulocytosis; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Survival Analysis; Thrombocytopenia; Treatment Outcome | 1999 |
GM-CSF accelerates neutrophil recovery after autologous bone marrow transplantation for Hodgkin's disease.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Colony-Stimulating Factors; Combined Modality Therapy; Cytarabine; Drug Evaluation; Etoposide; Granulocytes; Hodgkin Disease; Humans; Leukocyte Count; Macrophages; Melphalan; Neutropenia; Neutrophils; Postoperative Complications; Recombinant Proteins; Transplantation, Autologous | 1989 |
21 other study(ies) available for etoposide and Agranulocytosis
Article | Year |
---|---|
[Doxorubicin and etoposide-besed combination chemotherapy regimen for peripheral T-cell lymphoma].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Nausea; Prednisone; Remission Induction; Vincristine; Young Adult | 2008 |
Case report: clozapine given in the context of chemotherapy for lung cancer.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Antipsychotic Agents; Carcinoma, Small Cell; Cisplatin; Clozapine; Comorbidity; Cooperative Behavior; Drug Interactions; Etoposide; Humans; Leukocyte Count; Lung Neoplasms; Neoplasm Staging; Palliative Care; Patient Care Team; Quality of Life; Referral and Consultation; Remission Induction; Schizophrenia, Paranoid | 2008 |
Chemotherapy versus chemoimmunotherapy for small-cell undifferentiated carcinoma of the lung.
Topics: Aged; Agranulocytosis; Alopecia; Antineoplastic Agents; BCG Vaccine; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Prognosis; Prospective Studies; Vomiting | 1980 |
Cisplatin, adriamycin, and etoposide (CAV) for remission induction of small-cell bronchogenic carcinoma.
Topics: Adult; Aged; Agranulocytosis; Bone Marrow Transplantation; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Leukocyte Count; Male; Middle Aged; Pilot Projects; Podophyllotoxin; Thrombocytopenia | 1982 |
Acute myelogenous leukemia: successful treatment of relapse with cytosine arabinoside, VP 16-213, vincristine and vinblastine (A-triple-V).
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Therapy, Combination; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence; Thrombocytopenia; Vinblastine; Vincristine | 1982 |
Oral Fusarium infection in a granulocytopenic patient with acute myelogenous leukemia: a case report.
Topics: Acute Kidney Injury; Aged; Agranulocytosis; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Epirubicin; Etoposide; Fatal Outcome; Fusarium; Gingival Diseases; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Maxillary Diseases; Mercaptopurine; Mycoses; Necrosis; Prednisolone; Ulcer; Vindesine | 1995 |
A comparison of two GM-CSF schedules to counteract the granulo-monocytopenia of carboplatin-etoposide chemotherapy.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukocyte Count; Male; Middle Aged; Platelet Count; Time Factors | 1995 |
VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung cancer.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Treatment Outcome | 1994 |
High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study.
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms; Pilot Projects; Prognosis; Prospective Studies; Salvage Therapy; Thrombocytopenia | 1993 |
Dose-intensive chemotherapy with etoposide-cyclophosphamide for advanced breast cancer. North American Marrow Transplant Group.
Topics: Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-3; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Thrombocytopenia; Treatment Outcome | 1996 |
Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents; Camptothecin; Carcinoma, Small Cell; Cisplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Thrombocytopenia; Topotecan | 1996 |
Treatment of patients with high-grade non-Hodgkin's lymphoma aged over 70 years with an all-oral regimen combining idarubicin, etoposide and alkylators.
Topics: Administration, Oral; Age Factors; Aged; Aged, 80 and over; Agranulocytosis; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Male; Prednimustine; Thrombocytopenia; Treatment Outcome | 2000 |
[T-cell rich B-cell lymphoma associated with hemophagocytic syndrome].
Topics: Adult; Agranulocytosis; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Granulocyte-Macrophage Colony-Stimulating Factor; Histiocytosis, Non-Langerhans-Cell; HLA-DR Antigens; Humans; Liver Neoplasms; Lymph Nodes; Lymphoma, T-Cell; Macrophages; Male; Prednisone; Splenic Neoplasms; Vincristine | 1992 |
Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Clinical Protocols; Clinical Trials, Phase II as Topic; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Middle Aged; Remission Induction; Survival Rate | 1992 |
Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neutropenia; Prospective Studies; Remission Induction; Survival Rate; Vomiting | 1992 |
Single institution experience with high-dose cyclophosphamide, continuous infusion vincristine, escalating doses of VP-16-213, and total body irradiation with unpurged bone marrow rescue in children with neuroblastoma.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dermatitis, Exfoliative; Diarrhea; Etoposide; Female; Humans; Infant; Male; Neuroblastoma; Stomatitis; Thrombocytopenia; Vincristine | 1992 |
Use of recombinant human hematopoietic growth factors and autologous bone marrow transplantation to attenuate the neutropenic trough of high-dose therapy.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Specimen Collection; Bone Marrow Transplantation; Carmustine; Colony-Stimulating Factors; Cyclophosphamide; Etoposide; Granulocyte Colony-Stimulating Factor; Granulocytes; Hodgkin Disease; Humans; Male; Neutropenia; Neutrophils; Pain; Recombinant Proteins | 1990 |
Phase I study of repeated cycles of high-dose cyclophosphamide, etoposide, and cisplatin administered without bone marrow transplantation.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms; Remission Induction; Survival Rate; Thrombocytopenia | 1990 |
Length of follow-up in teratomas--results of a modification of Einhorn's regime in testicular teratomas.
Topics: Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Prognosis; Teratoma; Testicular Neoplasms; Time Factors; Vinblastine | 1986 |
Effect of etoposide and cyclophosphamide on an experimental pulmonary infection in mice.
Topics: Agranulocytosis; Animals; Ceftriaxone; Cyclophosphamide; Etoposide; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases; Mice; Monocytes | 1989 |
Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors.
Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dysgerminoma; Etoposide; Female; Fever; Follow-Up Studies; Humans; Male; Nausea; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin; Prognosis; Teratoma | 1985 |